ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2023

The Emerging Safety Profile of JAK Inhibitors in Rheumatic Diseases.

Jasvinder A SinghPubMed ↗Publisher ↗

No numbers read from the abstract.